The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) COVID-19 vaccines (26)
- (-) Scheduling (national classification system) (8)
- Advertising (135)
- Regulatory compliance (74)
- COVID-19 (55)
- Prescription medicines (43)
- Therapeutic goods regulation (38)
- Vaping hub (25)
- Compliance and enforcement hub (17)
- Import and export (12)
- Medicinal cannabis hub (11)
- Complementary medicines (8)
- Labelling and packaging (8)
- Legislation (7)
- Medicine safety (7)
- Australian Register of Therapeutic Goods (ARTG) (6)
- Over the counter (OTC) medicines (6)
- Weight loss products (6)
- Safety (5)
- Alert/Advisory (4)
- Manufacturing (4)
- Non-prescription medicines (4)
- Shortages (4)
- Cosmetics (2)
- Listed medicines (2)
- Medical devices safety (2)
- Assessed listed medicines (1)
- In Vitro Diagnostic medical devices (IVDs) (1)
Search
34 result(s) found, displaying 1 to 25
-
BlogIf your business sells or advertises paracetamol, then you need to be aware of the new rules around pack sizes that commence on 1 February 2025.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesWe are providing a 12-month period of labelling exemptions for signal words for certain Pharmacy medicine and Pharmacist Only medicine products.
-
Media releasesWe are aware of misinformation that claims the COVID-19 mRNA vaccines are contaminated with excessive levels of DNA. This is not the case.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has published a final decision to reduce the maximum size of packs for various paracetamol products.
-
Media releasesFrom 1 June 2023, prescribing of oral ivermectin for ‘off-label’ uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesOn 17 February, the TGA granted provisional approval to Moderna’s bivalent COVID-19 vaccine. This is the second bivalent vaccine targeting the Omicron BA.4-5 subvariants that has been provisionally approved by the TGA
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.